MODULATION OF NORADRENALINE RELEASE FROM THE SYMPATHETIC-NERVES OF THE HUMAN SAPHENOUS-VEIN AND PULMONARY-ARTERY BY PRESYNAPTIC EP(3)-RECEPTOR AND DP-RECEPTOR
Gj. Molderings et al., MODULATION OF NORADRENALINE RELEASE FROM THE SYMPATHETIC-NERVES OF THE HUMAN SAPHENOUS-VEIN AND PULMONARY-ARTERY BY PRESYNAPTIC EP(3)-RECEPTOR AND DP-RECEPTOR, British Journal of Pharmacology, 111(3), 1994, pp. 733-738
1 Spirally cut strips of the human saphenous vein and pulmonary artery
were used to determine the pharmacological properties of the presynap
tic prostanoid receptors involved in the modulation of sympathetic [H-
3]-noradrenaline release. Strips preincubated with [H-3]-noradenaline
were superfused with physiological salt solution containing inhibitors
of uptake(1) and uptake(2) and rauwolscine to eliminate involvement o
f presynaptic alpha(2)-adrenoceptors. Tritium overflow was evoked by t
ransmural electrical stimulation (standard frequency: 2 Hz). 2 In the
saphenous vein, prostaglandin E(2) (PGE(2)) inhibited the electrically
-evoked tritium overflow; at the highest concentration investigated, t
ritium overflow was inhibited by more than 75% and the pEC(50) value w
as 7.00. These effects were mimicked by prostaglandin E(1), the EP(1)/
EP(3) receptor agonist, sulprostone and the EP(2)/EP(3) receptor agoni
st, misoprostol with the rank order(pEC(50)): sulprostone (8.60)>PGE(1
) (7.25)> misoprostol (6.96). This rank order of potency suggests that
the inhibitory effect of the drugs is mediated by presynaptic EP(3)-r
eceptors. In contrast, PGF(2 alpha), did not inhibit evoked tritium ov
erflow; the IP/EP(1) receptor agonist iloprost and the stable thrombox
ane A(2) analogue U 46619 (9, 11-dideoxy-11 alpha,9 alpha-epoxy-methan
oprostaglandin F-2 alpha) produced inhibition only at concentrations a
bove 1 mu M. 3 The EP(1)-receptor antagonist, AH 6809 (6-isopropoxy-9-
oxoxanthene-2-carboxylic acid) had no effect on the evoked tritium ove
rflow nor did it modify the inhibitory effect of PGE(2), further exclu
ding involvement of inhibitory presynaptic EP(1)-receptors. 4 PGD(2) c
aused a facilitation of evoked tritium overflow in the saphenous vein;
this facilitation is probably mediated by presynaptic DP-receptors, s
ince it was abolished by the selective DP-receptor antagonist, BW A868
C l)-1-(2-cyclohexyl-2-hydroxyethylamino)hydantoin). 5 In the pulmonar
y artery, sulprostone (pEC(50) value 8.35), misoprostol (7.70) and PGE
(2) (6.80) inhibited electrically-evoked tritium overflow. This rank o
rder of potency is consistent with the involvement of inhibitory presy
naptic EP(3)-receptors. 6 These results suggest that the sympathetic n
erve fibres of both human saphenous vein and pulmonary artery are endo
wed with presynaptic inhibitory EP(3) receptors. The EP(3)-receptors d
o not interact with the alpha(2)-autoreceptors. In addition, the human
saphenous vein seems to be endowed with presynaptic facilitatory DP-r
eceptors.